Basic Information
Basic information for LINC00343-281-22aa
Peptide Name LINC00343-281-22aa
Genome Position chr13:105761537-105761602[+]
Species Human
Peptide Sequence MWRWCLWEVTGLRCGREGGASW
Peptide Length 22
Unique No (LINC00343-203-22aa,LINC00343-222-22aa,LINC00343-230-22aa,LINC00343-233-22aa,LINC00343-237-22aa,LINC00343-239-22aa-2,LINC00343-240-22aa,LINC00343-244-22aa,LINC00343-248-22aa,LINC00343-263-22aa,LINC00343-273-22aa,LINC00343-275-22aa,LINC00343-284-22aa,LINC00343-296-22aa,LINC00343-297-22aa,LINC00343-302-22aa,LINC00343-307-22aa-2,LINC00343-318-22aa-2,LINC00343-320-22aa)
Grand Average of Hydropathicity -0.3045
Relative Molecular Mass 3018.38
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000666696;LINC00343-281
Transcript Length 1491
Coding Ability 0.4024
DNA Sequence Corresponding to Peptide ATGTGGAGATGGTGCCTTTGGGAGGTAACTGGGCTTAGATGTGGGCGTGAGGGTGGGGCCTCATGG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :